Patients with hepatic veno-occlusive disease finally have hope. Defibrotide sodium in India is gaining recognition as a critical treatment option. This specialised injection — 200 mg/2.5 mL (80 mg/mL) in a single-patient-use vial — is prescribed in serious post-transplant complications. Early access can genuinely save lives.